Aim: To determine the prevalence (cases per million inhabitants) of home artificial nutrition (HAN), enteral (HEN) and parenteral (HPN), in Italy, grouped according to administrative regions, patient age and primary disease, and to analyze the impact both of the presence of an HAN regional regulation and of demographic characteristics. Methods: In April 2005, the Regional Coordinators of the Italian Society for Parenteral and Enteral Nutrition (SINPE) recorded all the ongoing cases of HAN using a structured questionnaire and were asked to estimate the representativeness of the collected sample with respect to the total expected HAN. Results: A total of 6955 cases of HAN (93.5% adults, 6.5% pediatric patients p18 years) were recorded in 16 of the 20 Italian regions (80% of the Italian population; sample representativeness 78%). HAN prevalence 152.6 (83.9% HEN, 16.1% HPN); the HAN range among the regions was: prevalence 28.1–519.8; oncological disease 13.8–75.7%, neurological disease 15.5–79.9%, intestinal failure 1.3–14.0%. An HAN regulation was present in 11 regions. A positive association (P ¼ 0:012) was found between the number of years since the regulation was issued and the HAN prevalence, and also between the % neurological patients and the population density (P ¼ 0:130) and the % inhabitants X75 years (P ¼ 0:040).

Prevalence of home artificial nutrition in Italy in 2005: A survey by the Italian Society for Parenteral and Enteral Nutrition (SINPE).

CONTALDO, FRANCO;
2007

Abstract

Aim: To determine the prevalence (cases per million inhabitants) of home artificial nutrition (HAN), enteral (HEN) and parenteral (HPN), in Italy, grouped according to administrative regions, patient age and primary disease, and to analyze the impact both of the presence of an HAN regional regulation and of demographic characteristics. Methods: In April 2005, the Regional Coordinators of the Italian Society for Parenteral and Enteral Nutrition (SINPE) recorded all the ongoing cases of HAN using a structured questionnaire and were asked to estimate the representativeness of the collected sample with respect to the total expected HAN. Results: A total of 6955 cases of HAN (93.5% adults, 6.5% pediatric patients p18 years) were recorded in 16 of the 20 Italian regions (80% of the Italian population; sample representativeness 78%). HAN prevalence 152.6 (83.9% HEN, 16.1% HPN); the HAN range among the regions was: prevalence 28.1–519.8; oncological disease 13.8–75.7%, neurological disease 15.5–79.9%, intestinal failure 1.3–14.0%. An HAN regulation was present in 11 regions. A positive association (P ¼ 0:012) was found between the number of years since the regulation was issued and the HAN prevalence, and also between the % neurological patients and the population density (P ¼ 0:130) and the % inhabitants X75 years (P ¼ 0:040).
File in questo prodotto:
File Dimensione Formato  
Pironi_2007.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 382.66 kB
Formato Adobe PDF
382.66 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11588/101413
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact